Do You Need Hormone Replacement Therapy (HRT)? Signs, Safety, and What It Costs

Hormone replacement therapy (HRT) replaces the estrogen your ovaries stop producing at menopause, and it remains the most effective treatment for hot flashes, night sweats, and vaginal dryness. Whether it suits you depends less on symptom severity than on your age, how long it has been since your last period, and your personal risk factors. This guide covers the signs it may help, what the safety evidence actually shows, and what it costs.

What Is HRT, and Who Is It For?

HRT, also called menopausal hormone therapy, supplies estrogen to relieve symptoms caused by its decline. If you still have a uterus, a progestogen is added to protect the uterine lining from overgrowth, which unopposed estrogen would otherwise cause. If you have had a hysterectomy, estrogen alone is used.

It comes as tablets, patches, gels, and sprays, plus low-dose vaginal preparations that treat dryness and discomfort locally with minimal absorption into the bloodstream. The route of administration matters clinically, not just for convenience: transdermal formulations carry a lower risk of clot formation than oral formulations.

Read More: Hormonal Health and Women's Health: Symptoms, Causes, Diagnosis, and Treatment

Signs You Might Need HRT

No test determines whether you need HRT. Symptoms and their effect on your life drive the decision, not a hormone level.

The clearest indications are hot flashes and night sweats frequent enough to disrupt sleep, work, or daily functioning. Vaginal dryness, discomfort during sex, and recurrent urinary symptoms are a second cluster, and these tend to worsen over time rather than resolve on their own. Sleep disruption, mood changes, and joint aches that track with your cycle changes may also improve on treatment.

Two situations shift the calculation more strongly toward treatment. Early menopause before 45, or primary ovarian insufficiency before 40, carries higher long-term risks to bone and cardiovascular health, and hormone therapy is generally recommended at least until the average age of menopause. Significant bone density loss is also a recognized indication.

Equally, some conditions rule it out or require specialist input: a history of breast cancer, unexplained vaginal bleeding, blood clots, stroke, or active liver disease, among them.

That does not leave you without options. Several non-hormonal medications are used off-label to reduce hot flashes, and they are the usual route when estrogen is unsuitable or unwanted, alongside fezolinetant (Veozah), an FDA-approved non-hormonal drug that requires periodic liver blood tests, and low-dose paroxetine, which is FDA-approved for hot flashes: 

• Venlafaxine ER (Effexor XR)

• Desvenlafaxine (Pristiq)

• Paroxetine (Paxil)

• Fluoxetine (Prozac)

• Clonidine (Catapres)

Is HRT Safe? What the Evidence Actually Shows

This question deserves context because the fear attached to it stems from a specific, widely misread moment. When the Women's Health Initiative trial was halted early in 2002, coverage of its breast cancer and cardiovascular findings led to a collapse in prescribing worldwide. Less reported was that the average participant was 63, more than a decade past menopause, and taking a specific oral formulation.

Two decades of reanalysis have produced what is now called the timing hypothesis, which underpins current guidance. The Menopause Society's 2022 position statement concludes that for women under 60 or within 10 years of menopause onset, and without contraindications, the benefit-risk balance favors treatment for bothersome hot flashes and preventing bone loss. Starting more than 10 years out, or after 60, shifts that balance because the absolute risks of heart disease, stroke, and clots rise with age regardless.

Risk also depends on what you take and how. Estrogen-plus-progestogen therapy carries a small increase in breast cancer risk that grows with duration of use; estrogen alone, in women who have had a hysterectomy, does not show the same signal. Transdermal delivery and lower doses reduce the risk of clot and stroke relative to oral tablets. These distinctions are the substance of the conversation with your prescriber. Reflecting this evidence, the FDA moved in late 2025 to remove most of the broad boxed warnings from menopausal hormone therapy labels, though the specific risks above still apply and still belong in that conversation.

Does HRT Cause Weight Gain or Weight Loss?

Neither, in any meaningful sense, and both questions are heavily searched. A prospective study of early postmenopausal women found that combined therapy neither prevented nor increased weight gain, though it did reduce the shift toward abdominal fat storage that typically accompanies menopause. Later reviews are consistent with that.

So HRT is not a weight-loss treatment and should not be started as one. The weight changes most people notice in midlife are driven by the hormonal transition itself, declining muscle mass, and changes in sleep and activity, and those continue whether or not you take hormones.

One practical note: some people see the scale rise in the first weeks. That is usually fluid retention rather than fat, and it typically resolves within 1 to 3 months.

What Does HRT Cost, and Does Insurance Cover It?

Less than most people expect, if you use generics. Generic estradiol is among the least expensive prescription medications, commonly $10 to $30 per month, and generic micronized progesterone typically runs $30 to $80 per month. A complete regimen usually costs between $30 and $120 per month without insurance. The same combination in brand-name form can approach $300.

Most commercial plans and Medicare Part D cover FDA-approved hormone therapy, particularly generics, with copays commonly in the $5 to $50 range. A menopause diagnosis is generally sufficient to establish medical necessity. What is usually not covered: compounded bioidentical hormones and pellet therapy, which are also the most expensive options and are not FDA-approved.

• Estradiol (Estrace), the estrogen component

• Progesterone (Prometrium), added when you still have a uterus

Ask your prescriber to specify generics, and check whether a 90-day supply lowers your per-month cost.

What to Expect in the First Few Months

Hot flashes usually begin improving within 2 to 4 weeks, with the full effect by around 3 months. Vaginal symptoms take longer, often 1 to 3 months, for local treatment. Mood and sleep improvements, where they occur, tend to follow symptom relief rather than arriving independently.

Irregular bleeding or spotting is common in the first 3 to 6 months on continuous therapy as the uterine lining adjusts. Beyond that window, or if bleeding is heavy, evaluation is warranted rather than waiting.

Learn More: Hormonal Health and Women's Health: Symptoms, Causes, Diagnosis, and Treatment